Southern Tier Home Infusion, Inc. dba Pharmacy Innovations
FDA inspection history in Erie, Pennsylvania, 2022 to 2023
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2022: one Form 483; 2023: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2022–23One Form 483 and one warning letter, at Erie, Pennsylvania.
Cited most
Across all Southern Tier Home Infusion, Inc. dba Pharmacy Innovations observations on file
- 21 CFR 211.113Control of microbiological contamination5
- 21 CFR 211.42Design and construction features3
- 21 CFR 211.67Equipment cleaning and maintenance1
The complete Southern Tier Home Infusion, Inc. dba Pharmacy Innovations file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Erie, Pennsylvania
One warning letter and one Form 483 · 2022 to 2023 · 9 observations
Latest: Warning letter, Sep 20, 2023 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-09-20 | Warning letter Warning letter | Erie, Pennsylvania | — | $99 |
| 2022-11-30 | 483 Form 483 | Erie, Pennsylvania | 9 | $99 |
Investigators on these documents
FEI number 3004858203 · most recent document Sep 20, 2023
About Southern Tier Home Infusion, Inc. dba Pharmacy Innovations
How many FDA Form 483s has Southern Tier Home Infusion, Inc. dba Pharmacy Innovations received?
FDA Intel has 1 Form 483 on file for Southern Tier Home Infusion, Inc. dba Pharmacy Innovations; the most recent is dated Nov 30, 2022.
When was Southern Tier Home Infusion, Inc. dba Pharmacy Innovations last inspected by FDA?
The most recent FDA inspection document on file for Southern Tier Home Infusion, Inc. dba Pharmacy Innovations is a Form 483 dated Nov 30, 2022, for the site in Erie, Pennsylvania.
What did FDA cite at Southern Tier Home Infusion, Inc. dba Pharmacy Innovations?
The regulations cited most in the observations on file for Southern Tier Home Infusion, Inc. dba Pharmacy Innovations are 21 CFR 211.113 (Control of microbiological contamination), 5 times; 21 CFR 211.42 (Design and construction features), 3 times; 21 CFR 211.67 (Equipment cleaning and maintenance), 1 time.
Has Southern Tier Home Infusion, Inc. dba Pharmacy Innovations received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Southern Tier Home Infusion, Inc. dba Pharmacy Innovations; the most recent is dated Sep 20, 2023.